Sign In
Buy INFU
$9.14
-0.0500 (-0.544%)
At Close: Jul 31, 2026
InfuSystem Stock: Margin Expansion And Growth Strategy To Drive Strong Gains
10:57pm, Monday, 10'th Nov 2025
InfuSystem Holdings offers strong growth potential and appears attractively valued after reporting positive Q3 2025 earnings results. INFU's Patient Services segment, especially oncology and wound car
InfuSystem to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025
04:30pm, Monday, 10'th Nov 2025
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025.
InfuSystem Set To Be A Cash Cow In 2026
12:02pm, Monday, 10'th Nov 2025
InfuSystem (INFU) is prioritizing profitability and margin expansion under new CEO Carrie Lachance, shifting focus from unprofitable revenue streams. INFU's integration of Apollo Medical's billing sys
Wall Street Analysts Predict a 40% Upside in InfuSystems Holdings (INFU): Here's What You Should Know
10:56am, Thursday, 06'th Nov 2025
The consensus price target hints at a 40% upside potential for InfuSystems Holdings (INFU). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earning
Should Value Investors Buy InfuSystems Holdings (INFU) Stock?
10:40am, Thursday, 06'th Nov 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
InfuSystem Holdings, Inc. (INFU) Q3 2025 Earnings Call Transcript
12:56pm, Tuesday, 04'th Nov 2025
InfuSystem Holdings, Inc. ( INFU ) Q3 2025 Earnings Call November 4, 2025 9:00 AM EST Company Participants Carrie Lachance - President, CEO & Director Barry Steele - Executive VP & CFO Conference Call
InfuSystems Holdings, Inc. (INFU) Tops Q3 Earnings Estimates
08:51am, Tuesday, 04'th Nov 2025
InfuSystems Holdings, Inc. (INFU) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.08 per share a year ago.
InfuSystem Reports Third Quarter 2025 Financial Results
06:30am, Tuesday, 04'th Nov 2025
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Reports Third Quarter 2025 Financial Results.
Can Strength in Rental Business Drive INFU Stock Before Q3 Earnings?
12:00am, Tuesday, 04'th Nov 2025
InfuSystem eyes third-quarter 2025 gains as rental contracts and ERP upgrades boost margins across Patient Services and Device Solutions.
InfuSystem to Report Third Quarter 2025 Financial Results on November 4, 2025
04:30pm, Tuesday, 28'th Oct 2025
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report Third Quarter 2025 Financial Results on November 4, 2025.
5 Best Stocks For Mild Stagflation
08:00am, Tuesday, 28'th Oct 2025
Inflation is expected to remain sticky and GDP expected to range between 1.7 to 2.1% in 2026. The U.S. may avoid stagflation, but mild forms are present and may linger. While investors won't likely ne
Head to Head Comparison: H-CYTE (OTCMKTS:HCYTD) versus InfuSystem (NYSE:INFU)
01:14am, Monday, 20'th Oct 2025
H-CYTE (OTCMKTS:HCYTD - Get Free Report) and InfuSystem (NYSE: INFU - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based o
Here's Why Momentum in InfuSystems Holdings (INFU) Should Keep going
09:51am, Monday, 06'th Oct 2025
If you are looking for stocks that are well positioned to maintain their recent uptrend, InfuSystems Holdings (INFU) could be a great choice. It is one of the several stocks that passed through our "R
InfuSystem to Present at 4th Annual ROTH Healthcare Opportunities Conference on October 9, 2025
04:29pm, Thursday, 25'th Sep 2025
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Present at 4th Annual ROTH Healthcare Opportunities Conference on October 9, 2025.
4 Top-Ranked Stocks With Solid Net Profit Margins to Boost Returns
10:15am, Wednesday, 24'th Sep 2025
INFU, CENX, RELY and GLDD boast strong net margins, rising earnings and bullish analyst ratings that signal upside.
